Australian Aerospace & Defense Stock News

As the Australian market navigates a festive atmosphere reminiscent of past highs, optimism remains palpable despite ongoing tech jitters and fluctuating commodity prices. In this context, identifying stocks that are undervalued relative to their intrinsic value can offer significant opportunities for investors looking to capitalize on potential market inefficiencies.

The Australian market has been buzzing with activity, reflecting a festive spirit reminiscent of October's highs, despite ongoing tech jitters and fluctuating oil prices. For investors interested in smaller or newer companies, penny stocks—although the term might sound outdated—offer intriguing opportunities for value and growth. This article explores several ASX penny stocks that exhibit financial strength and potential, making them appealing options for those seeking promising investments...

Whitehaven Coal (ASX:WHC) has just doubled down on shareholder returns, unveiling a new A$72 million buyback for up to 4.48% of its shares, alongside an update on its earlier repurchase progress. See our latest analysis for Whitehaven Coal. The fresh A$72 million buyback lands on top of a strong run, with a 30 day share price return of 10.68% and a 90 day gain of 22.56%. The 5 year total shareholder return of 495.19% shows how powerful capital returns and cash generation have been over a...

Aristocrat Leisure (ASX:ALL) just packed several investor friendly updates into one move, combining a fresh buy back progress report, its 2025 Annual Report release, reiterated FY26 growth guidance, and a Fitch credit upgrade. See our latest analysis for Aristocrat Leisure. Those updates come after a tough stretch for the stock, with a roughly 17 percent year to date share price decline and weaker recent momentum, even though the five year total shareholder return is still close to doubling...

The catalyst here is clear. Neuren Pharmaceuticals (ASX:NEU) just secured FDA approval for DAYBUE STIX, a new powder version of its Rett syndrome therapy that could broaden usage and deepen royalty streams. See our latest analysis for Neuren Pharmaceuticals. The market seems to be recognising that story, with the share price at A$19.28 after a strong year to date share price return of about 57 percent and a standout five year total shareholder return above 1,400 percent. This suggests...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

The Australian market is experiencing a period of uncertainty, with shares opening flat and lacking the anticipated end-of-year rally. Despite this cautious atmosphere, there are still opportunities for investors to explore, particularly in the realm of penny stocks. Although the term "penny stocks" may seem outdated, these smaller or newer companies can offer intriguing prospects for those willing to look beyond larger firms.

DroneShield (ASX:DRO) just landed a €2.8 million contract with Belgium for handheld drone jammers, a deal that neatly captures how fast European demand for counter drone tech is moving from trials to real deployment. See our latest analysis for DroneShield. The contract lands as DroneShield’s A$2.3 share price rides powerful momentum, with a 1 day share price return of 10.6 percent and year to date share price return above 200 percent. Its 1 year total shareholder return of roughly 274...

It's not a stretch to say that Income Asset Management Group Limited's ( ASX:IAM ) price-to-sales (or "P/S") ratio of...

With the business potentially at an important milestone, we thought we'd take a closer look at VBX Limited's ( ASX:VBX...

In early December 2025, Koninklijke Philips held a special call announcing a significant expansion of its distribution agreement for 4DMedical’s FDA-cleared, non-contrast CT:VQ ventilation and perfusion imaging solution. This move could materially widen commercial access to CT:VQ by leveraging Philips’ global imaging footprint, potentially accelerating hospital adoption of 4DMedical’s technology. We’ll now examine how the expanded Philips distribution for CT:VQ may influence 4DMedical’s...

It's not a stretch to say that Infotrust Ltd's ( ASX:ITS ) price-to-sales (or "P/S") ratio of 0.9x right now seems...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Although Fortifai Limited ( ASX:FTI ) shareholders have enjoyed a great week with the stock up 39%, insiders who sold...

Insiders who purchased AU$559.4k worth of Terragen Holdings Limited ( ASX:TGH ) shares over the past year recouped some...

It's not a stretch to say that Enero Group Limited's ( ASX:EGG ) price-to-sales (or "P/S") ratio of 0.3x right now...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

AGL Energy (ASX:AGL) has joined Origin in courting private capital for its green energy and utility assets, marking a strategic shift that could reshape how investors think about funding Australia’s energy transition. See our latest analysis for AGL Energy. The latest push to bring private capital into AGL’s renewables and grid assets comes after a choppy year, with a negative year to date share price return but a solid three year total shareholder return. This signals that longer term...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Most readers would already know that Endeavour Group's (ASX:EDV) stock increased by 2.2% over the past month. Given...

Insiders who bought HITIQ Limited ( ASX:HIQ ) stock lover the last 12 months are probably not as affected by last...

Key Insights Significant control over Catapult Sports by retail investors implies that the general public has more...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...